Nisa Investment Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

$25.4 Billion
Q3 2025

A detailed history of Nisa Investment Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 61,258 shares of RXRX stock, worth $253,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,258

Previous 3,815 1505.71%

Holding current value

$253,608

Previous $19,000 1468.42%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$4.52 - $6.54 $259,642 - $375,677	57,443 Added 1505.71%	61,258 $298,000
Q2 2025 Jul 31, 2025	BUY	$3.97 - $5.84 $3,453 - $5,080	870 Added 29.54%	3,815 $19,000
Q1 2025 Apr 30, 2025	BUY	$5.29 - $10.87 $2,428 - $4,989	459 Added 18.46%	2,945 $15,000
Q4 2024 Jan 17, 2025	BUY	$5.7 - $8.27 $900 - $1,306	158 Added 6.79%	2,486 $16,000
Q3 2024 Oct 24, 2024	BUY	$5.92 - $8.6 $1,793 - $2,605	303 Added 14.96%	2,328 $15,000
Q2 2024 Jul 19, 2024	BUY	$7.35 - $10.05 $5,497 - $7,517	748 Added 58.57%	2,025 $15,000
Q1 2024 May 01, 2024	BUY	$9.13 - $15.52 $1,113 - $1,893	122 Added 10.56%	1,277 $12,000
Q4 2023 Jan 25, 2024	SELL	$5.09 - $10.79 $14,582 - $30,913	-2,865 Reduced 71.27%	1,155 $11,000
Q3 2023 Nov 02, 2023	SELL	$6.59 - $15.86 $131 - $317	-20 Reduced 0.5%	4,020 $30,000
Q2 2023 Aug 11, 2023	SELL	$4.56 - $9.94 $211,173 - $460,321	-46,310 Reduced 91.98%	4,040 $30,000
Q1 2023 May 02, 2023	BUY	$6.42 - $9.64 $128 - $192	20 Added 0.04%	50,350 $336,000
Q4 2022 Feb 02, 2023	SELL	$7.16 - $12.7 $386 - $685	-54 Reduced 0.11%	50,330 $388,000
Q3 2022 Nov 07, 2022	SELL	$7.83 - $13.6 $211,378 - $367,145	-26,996 Reduced 34.89%	50,384 $536,000
Q2 2022 Aug 03, 2022	BUY	$5.04 - $9.26 $384,552 - $706,538	76,300 Added 7064.81%	77,380 $630,000
Q1 2022 Apr 29, 2022	BUY	$6.16 - $18.03 $6,652 - $19,472	1,080 New	1,080 $8,000
Q4 2021 Feb 03, 2022	SELL	$16.14 - $21.86 $44,820 - $60,705	-2,777 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$19.03 - $41.33 $52,846 - $114,773	2,777 New	2,777 $64,000

Others Institutions Holding RXRX

# of Institutions

361

Shares Held

301M

Call Options Held

7.71M

Put Options Held

4.85M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $747M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History